Displaying drugs 101 - 125 of 136 in total
| DrugBank ID | Name CAS Number |
Weight Formula |
Structure | Categories | Therapeutic Indication |
|---|---|---|---|---|---|
| DB01285 |
Corticotropin
9002-60-2 |
4541.0658 C207H308N56O58S |
|
Diagnostic Agents | For use as a diagnostic agent in the screening of patients presumed to have adrenocortical insufficiency. |
| DB00048 |
Collagenase
9001-12-1 |
112023.2000 C5028H7666N1300O1564S21 |
|
Anti-Ulcer Agents / Topical | Used to promote debridement of necrotic tissue in the treatment of severe burns and dermal ulcers including decubitus ulcers. |
| DB00036 |
Coagulation factor VIIa
9001-25-6 |
45079.1000 C1972H3076N560O597S28 |
|
Coagulants / Thrombotic Agents | For treatment of hemorrhagic complications in hemophilia A and B |
| DB00100 |
Coagulation Factor IX
9001-28-9 |
46548.2000 C2041H3136N558O641S25 |
|
Coagulants / Thrombotic Agents | For treatment of hemophilia (Christmas disease). |
| DB00097 |
Choriogonadotropin alfa
177073-44-8 |
25719.7000 C1105H1770N318O336S26 |
|
Fertility Agents / Gonadotropins | For the treatment of female infertility |
| DB00002 |
Cetuximab
205923-56-4 |
145781.6000 C6484H10042N1732O2023S36 |
|
Antineoplastic Agents | For treatment of EGFR-expressing metastatic colorectal cancer in patients who are refractory to other irinotecan-based chemotherapy regimens. Cetux... |
| DB00089 |
Capromab
145464-28-4 |
|
Imaging Agents | For diagnosis of prostate cancer and detection of intra-pelvic metastases. | |
| DB06168 |
Canakinumab
914613-48-2 |
145200.0000 C6452H9958N1722O2010S42 |
|
Investigated for use/treatment in rheumatoid arthritis, juvenile rheumatoid arthritis, inflammatory disorders (unspecified), and autoimmune diseases. | |
| DB06719 |
Buserelin
57982-77-1 |
|
|||
| DB00042 |
Botulinum Toxin Type B
93384-44-2 |
150804.0000 |
|
Antidystonic Agents | For the treatment of patients with cervical dystonia to reduce the severity of abnormal head position and neck pain associated with cervical dystonia. |
| DB00083 |
Botulinum Toxin Type A
93384-43-1 |
149322.7000 C6760H10447N1743O2010S32 |
|
Anti-Wrinkle Agents / Antidystonic Agents / Neuromuscular Blocking Agents | For the treatment of cervical dystonia in adults to decrease the severity of abnormal head position and neck pain associated with cervical dystonia... |
| DB00006 |
Bivalirudin
128270-60-0 |
2180.2853 C98H138N24O33 |
|
Anticoagulants / Antithrombotic Agents | For treatment of heparin-induced thrombocytopenia and for the prevention of thrombosis. Bivalirudin is indicated for use in patients undergoing p... |
| DB00112 |
Bevacizumab
216974-75-3 |
|
Antiangiogenesis Agents / Antineoplastic Agents | As part of combination therapy for metastatic colorectal cancer and HER2-negative metastatic breast cancer. | |
| DB08879 |
Belimumab
356547-88-1 |
147 kDa C 6358 H 9904 N 1728 O 2010 S 44 |
|
Monoclonal Antibody / Immunosuppressive Agents | Adjunct treatment of autoantibody-positive active systemic lupus erythematosus |
| DB06681 |
Belatacept
706808-37-9 |
90 kDa C3508H5440N922O1096S32 |
|
Immunosuppressive Agents | For prophylaxis of organ rejection. It is also used concomitantly with basiliximumab for induction therapy, mycophenolate, and corticosteriods in k... |
| DB00102 |
Becaplermin
165101-51-9 |
12294.4000 C532H892N162O153S9 |
|
Anti-Ulcer Agents / Topical | For topical treatment of skin ulcers (from diabetes) |
| DB00074 |
Basiliximab
152923-56-3 |
143801.3000 C6378H9844N1698O1997S48 |
|
Immunomodulatory Agents / Immunosuppressive Agents | For prophylactic treatment of kidney transplant rejection |
| DB00023 |
Asparaginase
9015-68-3 |
31731.9000 C1377H2208N382O442S17 |
|
Antineoplastic Agents | For treatment of acute lympocytic leukemia and non-Hodgkins lymphoma |
| DB00113 |
Arcitumomab
154361-48-5 |
144482.5000 C6398H9900N1714O1995S54 |
|
Diagnostic Agents / Imaging Agents | For imaging colorectal tumors |
| DB06692 |
Aprotinin
9087-70-1 |
6511.4390 C284H432N84O79S7 |
|
Antifibrinolytic Agents | For prophylactic use to reduce perioperative blood loss and the need for blood transfusion in patients undergoing cardiopulmonary bypass in the cou... |
| DB00098 | Antithymocyte globulin |
|
Immunomodulatory Agents | For prevention of renal transplant rejection | |
| DB00025 | Antihemophilic Factor |
264725.5000 C11794H18314N3220O3553S83 |
|
Coagulants / Thrombotic Agents | For the treatment of hemophilia A, von Willebrand disease and Factor XIII deficiency. |
| DB00029 |
Anistreplase
81669-57-0 |
59042.3000 C2569H3928N746O781S40 |
|
Thrombolytic Agents | For lysis of acute pulmonary emboli, intracoronary emboli and management of myocardial infarction |
| DB00026 |
Anakinra
143090-92-0 |
17257.6000 C759H1186N208O232S10 |
|
Antirheumatic Agents / Immunomodulatory Agents | For the treatment of adult rheumatoid arthritis. |
| DB00009 |
Alteplase
105857-23-6 |
59042.3000 C2569H3928N746O781S40 |
|
Thrombolytic Agents | For management of acute myocardial infarction, acute ischemic strok and for lysis of acute pulmonary emboli |
Displaying drugs 101 - 125 of 136 in total